In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

It's been a successful Champions League campaign so far for the six Premier League sides who entered -- but there's still plenty to play for ahead of the final matchweek. Here, ESPN rounds up what ...

While Arsenal have already booked their place in the last 16 of the Champions League, the remaining five Premier League clubs still have work to do in the final round of league-phase fixtures. First, ...